glp-1 indianapolis Indianapolis-based Eli Lilly's weight loss pill π just got speedy approval from the FDA. Here's how much it could cost. #weightloss #glp1 #weightlosspill #healthnews IU and Eli Lilly team
Description
Providers evaluate each patient's medical history, overall health, and weight-loss goals before recommending treatment
As recent studies show the amount of people taking glucagon-like peptide-1 receptor agonists (GLP-1 agonists) for weight loss, and not for managing type 2 diabetes as originally used, researchers have been examining these medications for potential positive and negative side effects
Endocrinol Diabetes Metab 2018;2:e00051
The goal is not to stop weight loss
Ongoing coaching Medication alone is not the full solution
